| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 06/27/2013 | WO2013093499A1 A composition |
| 06/27/2013 | WO2013091080A1 Vesicular stomatitis virus for prime boost vaccines |
| 06/27/2013 | WO2013026054A3 Production of infectious rna viruses in yeast |
| 06/27/2013 | US20130164821 Method for separating viruses from a contaminant-containing liquid |
| 06/27/2013 | US20130164735 Method of measuring human cyp3a inducibility |
| 06/27/2013 | US20130164374 Reduction in bacterial colonization by administering bacteriophage compositions |
| 06/27/2013 | US20130164329 Cell-based methods and reagents |
| 06/27/2013 | US20130164327 Adenovirus vaccine vectors |
| 06/27/2013 | US20130164262 Recombinant Viruses and their Use for Treatment of Atherosclerosis and Othe Forms of Coronary Artery Disease and Method, Reagent, and Kit for Evaluating Susceptibiity to Same |
| 06/26/2013 | EP2606127A2 Adenoviral assembly method |
| 06/26/2013 | CN103180446A Vesicular stomatitis viruses |
| 06/26/2013 | CN103173496A Method for establishing tree-shrew breast cancer model for slow virus by nipple injection |
| 06/26/2013 | CN103173495A Novel rabies virus fake virus system as well as preparation and application thereof |
| 06/26/2013 | CN103173492A Replicative HBV (Hepatitis B Virus) vector carrying foreign gene and recombinant HBV generated after transfection and corresponding preparation method and application |
| 06/26/2013 | CN103173470A Preparation of PCV2 ORF2 capsid protein virus-like particles derived from escherichia coli |
| 06/26/2013 | CN103172718A Plant low nitrogen stress resistant related protein GmDUF-CBS and encoding gene and application thereof |
| 06/26/2013 | CN103172717A Plant low potassium stress resistant related protein GmWRKY50 as well as encoding gene and application thereof |
| 06/26/2013 | CN103172710A Modified influenza virus for monitoring and improving vaccine efficiency |
| 06/26/2013 | CN102268457B Alpha-fetoprotein (AFP) recombinant adeno associated virus, and construction method and application thereof |
| 06/26/2013 | CN101619324B Replication defective recombinant adenovirus Ad41 vector system and application thereof |
| 06/26/2013 | CN101454023B Defective interfering virus |
| 06/26/2013 | CN101316617B Countermeasure against infection with floating virus |
| 06/25/2013 | US8470598 Modified Vaccinia Ankara virus variant and cultivation method |
| 06/25/2013 | US8470578 Purification of vaccinia viruses using hydrophobic interaction chromatography |
| 06/25/2013 | US8470577 Viral vectors and their use in therapeutic methods |
| 06/25/2013 | US8470310 Simian adenoviruses SAdV-36, -42.1, -42.2, and -44 and uses thereof |
| 06/25/2013 | CA2555412C Virus purification methods |
| 06/25/2013 | CA2492097C Signal for packaging of influenza virus vectors |
| 06/20/2013 | WO2013090795A1 Novel attenuated poliovirus: pv-1 mono-cre-x |
| 06/20/2013 | WO2013087945A2 Influenza virus reassortment |
| 06/20/2013 | WO2013068743A9 Novel bacteriophages |
| 06/20/2013 | WO2013052811A3 Affenadenorirus (gorilla) or adenoviral vectors and methods of use |
| 06/20/2013 | US20130157357 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 06/20/2013 | US20130156810 Influenza hemagglutinin and neuraminidase variants |
| 06/20/2013 | US20130156808 Vaccine comprising beta-herpesvirus |
| 06/20/2013 | US20130156736 Complementing cell lines |
| 06/19/2013 | EP2604695A1 Replication-defective arenavirus vectors |
| 06/19/2013 | EP2603234A1 Method for reducing dna impurities in viral compositions |
| 06/19/2013 | EP2603100A2 Dry storage stabilizing composition for biological materials |
| 06/19/2013 | CN103168100A Permanent human amniocyte cell lines for producing influenza viruses |
| 06/19/2013 | CN103167880A Inactivated varicella zoster virus vaccines, methods of production, and uses thereof |
| 06/19/2013 | CN103160524A Bombyx mori glutathione-S-transferase BmGSTe4 gene |
| 06/19/2013 | CN103160478A Optimized technological method for amplifying recombinant adenovirus by using bioreactor |
| 06/19/2013 | CN103160477A Method for improving Japanese encephalitis virus titer |
| 06/19/2013 | CN103160476A Method of isolated culturing various viruses |
| 06/19/2013 | CN103160475A Enterovirus 71 type viral strain, its application, vaccine and preparation method |
| 06/19/2013 | CN103160474A Enterovirus 71 type virus strain, vaccine, animal model establishment method |
| 06/19/2013 | CN103160473A Composition for recovering measles virus, and kit, purpose and method thereof |
| 06/19/2013 | CN103160457A Large-scaled cell-culturing proliferating method and method for using proliferated cell in virus production |
| 06/19/2013 | CN103159848A Two series major vault protein of glucagon-like peptide-2 of people and preparation method thereof |
| 06/19/2013 | CN103157115A Application of human RHBDD1 gene and drugs related to gene |
| 06/19/2013 | CN103157114A Purposes and related medicines of human ZNF786 gene |
| 06/19/2013 | CN103157107A Chicken Marek's disease vaccine produced by using continuous passage cell line and production method |
| 06/19/2013 | CN103157106A Method for preparing porcine parvovirus inactivated vaccines |
| 06/19/2013 | CN103157105A Method for preparing swine fever live vaccines |
| 06/19/2013 | CN103157103A Functional influenza virus-like particles (vlps) |
| 06/19/2013 | CN103157102A Method for preparing duck hemorrhagic ovaritis inactivated vaccines |
| 06/19/2013 | CN102586197B Method for nanometer adsorption and enrichment of water viruses in living water of large-volume aquatic animals and kit |
| 06/19/2013 | CN102533797B Preparation method for recombinant coxsackie virus A16 like particle and applications thereof |
| 06/19/2013 | CN102373180B Recombinant duck enteritis virus (DEV) vaccine strain for expressing avian influenza virus haemagglutinin (HA) gene and constructing method and application thereof |
| 06/19/2013 | CN101318016B Multivalent human-bovine rotavirus vaccine |
| 06/18/2013 | US8465971 Method for controlling biological function with mechanical vibration and device therefor |
| 06/18/2013 | US8465960 Influenza B viruses with reduced sensitivity to neuraminidase inhibitors |
| 06/18/2013 | CA2603711C Infectious, chimeric hepatitis c virus, methods of producing the same and methods of use thereof |
| 06/18/2013 | CA2561245C Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof |
| 06/18/2013 | CA2415187C Dna vaccines encoding hiv accessory proteins |
| 06/13/2013 | WO2013083753A2 Identification of a swine parecho-like virus and applications |
| 06/13/2013 | WO2013015668A3 Use of the peptide gk-1 expressed in the filamentous phage m13 for preparing pharmaceutical products that increase the effectiveness of the immune response induced by vaccine antigens or pathogens |
| 06/13/2013 | US20130149334 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 06/12/2013 | EP2600894A1 Modified hepatitis c virus proteins |
| 06/12/2013 | EP2600893A1 Inactivated varicella zoster virus vaccines, methods of production, and uses thereof |
| 06/12/2013 | EP2600892A2 Modified infectious laryngotracheitis virus (iltv) and uses thereof |
| 06/12/2013 | CN103154242A Norovirus derived immunogenic compositions and methods |
| 06/12/2013 | CN103153051A Crop protection agents containing insect-pathogenic viruses, in particular baculoviruses, and cellulose sulfate |
| 06/12/2013 | CN103146752A Method of applying adenovirus vector mediation ribose nucleic acid (RNA) jamming technology to silence sterol regulatory element binding protein 1 |
| 06/12/2013 | CN103146717A Insecticidal gene and use thereof |
| 06/12/2013 | CN103146657A In-vivo imaging tracking system of mouse hepatitis coronavirus and application of tracing system |
| 06/12/2013 | CN103146656A GFP (Green Fluorescent Protein) tracing system of mouse hepatitis coronavirus and application of tracing system |
| 06/12/2013 | CN103146655A Seed selection of high-immunogenicity rabies virus fixed strain and application thereof in vaccine development |
| 06/12/2013 | CN103146654A Artificially weakened infectious bronchitis virus and application thereof |
| 06/12/2013 | CN103146653A Infectious bursal disease virus chick embryo fibroblast adapted strain H11 and application thereof |
| 06/12/2013 | CN103145850A Substrate protein SNVP, and coding gene and application thereof |
| 06/12/2013 | CN103145814A Insecticidal protein, and coding gene and use thereof |
| 06/12/2013 | CN103143009A Method for producing duck tembusu virus inactivated vaccines in large scale |
| 06/12/2013 | CN103143008A Duck tembusu virus living vaccine and preparation method thereof |
| 06/12/2013 | CN103143007A Method for preparing infectious bursal disease virus live vaccine by utilizing passage chicken embryo fibroblast |
| 06/12/2013 | CN102766603B Chicken Newcastle disease virus and its separation method |
| 06/12/2013 | CN102559606B A16 type strain of Coxsackie virus and application of the strain |
| 06/12/2013 | CN102533675B Recombinant newcastle disease virus LaSota vaccine strain for expressing nipah encephalitis virus F protein |
| 06/12/2013 | CN102397539B Duckling flavivirus disease inactivated vaccine and preparation method thereof |
| 06/12/2013 | CN102286432B Method for building animal model of coxsachie virus 16 (CA16) infection and kit |
| 06/12/2013 | CN102219841B Phytomass-related protein as well as coding gene and application thereof |
| 06/12/2013 | CN102203242B Method for the production of adenoviral vectors |
| 06/12/2013 | CN102178946B Application of baby hamster kidney(BHK)-21 cell serum-free suspension culture technology in foot-and-mouth disease vaccine production |
| 06/12/2013 | CN101983238B Method for concentration of virus |
| 06/12/2013 | CN101875931B siRNA recombinant slow virus for inhibiting human hephaestin gene expression and application |
| 06/12/2013 | CN101768575B Construction of recombinant rabies virus of double-expression G gene and biological property analysis thereof |
| 06/11/2013 | US8460914 Decreasing potential iatrogenic risks associated with vaccines and vaccine antigens |
| 06/11/2013 | US8460913 Promoterless cassettes for expression of alpha virus structural proteins |
| 06/11/2013 | US8460912 Nucleic acid construct containing full length genome of human hepatitis C virus, recombinant full length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle |